Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pila Pharma
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
22 Fév 2024
Equity reseach Viva Wine Group, Q4 2023: Strong growth, but profitability on the soft side
Equity Research
Viva Wine Group
22 Fév 2024
Equity Research ALM Equity, Q4 2023: Consolidates operations with a larger associate
Equity Research
ALM Equity
21 Fév 2024
Equity research Nosa Plugs Q4, 2023: Record-breaking sales funding the pipeline
Equity Research
Nosa Plugs
21 Fév 2024
Carlsquare weekly market letter: All eyes on Nvidia!
Equity Research
Carlsquare
19 Fév 2024
Equity Research Viva Wine Grooup: Preview, Q4 2023
Equity Research
Viva Wine Group
19 Fév 2024
Equity Research Ecoclime, Q4 2023: Lower costs set the stage for future profits
Equity Research
16 Fév 2024
First Impression Ecoclime, Q4 2023: Lower costs indicate rationalization
Equity Research
16 Fév 2024
Equity Research Nosa Plugs: First impression Q4, 2023
Equity Research
Nosa Plugs
15 Fév 2024
Equity research HANZA Q4 2023: Going on the offensive in a slower market
Equity Research
Hanza
14 Fév 2024
Carlsquare weekly market letter: Is a change of the wind in the making?
Equity Research
Carlsquare
13 Fév 2024
Equity research HANZA: First impression Q4, 2023
Equity Research
Hanza
12 Fév 2024
First Impression H&D Wireless, Q4 2023: Good order intake but poor results
Equity Research
09 Fév 2024
Carlsquare Equity Research: Swedish industrials sector snapshot
Equity Research
Candles Scandinavia
07 Fév 2024
Carlsquare weekly market letter: Getting closer to the magic line of 5000
Equity Research
Carlsquare
06 Fév 2024
Equity research, HANZA: Preview Q4, 2023
Equity Research
Hanza
06 Fév 2024
Equity Research Nosa Plugs: drug delivery taking a big first step
Equity Research
Nosa Plugs
02 Fév 2024
Equity research Biosergen: Rights issue to fund the next clinical step
Equity Research
Biosergen
31 Jan 2024
Carlsquare Equity Research: Biotech snapshot Q4
Equity Research
Kancera
31 Jan 2024
Carlsquare weekly market letter: Follow the wind!
Equity Research
Carlsquare
30 Jan 2024
Mrkt BUZZ: Enrad set to benefit from new F-Gas regulation
Equity Research
Enrad
1
…
16
17
18
19
20
…
64